Pellficure Pharmaceuticals, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 14
Rang # Quantité totale PI 108 168
Note d'activité PI 0,4/5.0    1
Rang # Activité PI 927 970
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

6 1
2 0
5 0
0
 
Dernier brevet 2019 - Compositions and methods for tre...
Premier brevet 2011 - Novel treatment of prostate carc...
Dernière marque 2014 - PELLFICURE PHARMACEUTICALS
Première marque 2014 - PELLFICURE PHARMACEUTICALS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2018 Invention Compositions and methods for treatment of prostate carcinoma. Disclosed herein are 1,4-naphthoqui...
Invention Treatment of prostate carcinoma. Disclosed herein are naphthoquinone analogs, such as plumbagin, ...
Invention Compositions and methods for the treatment of cancer. Disclosed herein pharmaceutical composition...
Invention Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1,4-dione. Disclosed herein are pha...
2017 Invention Novel treatment of prostate carcinoma. Disclosed herein are naphthoquinone analogs, such as plum...
Invention Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1,4-dione. Disclosed herein are phar...
Invention Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione. Disclosed herein are pha...
2014 P/S Medicaments for prostate cancer
Invention Novel therapy for prostate carcinoma. Disclosed herein are methods of inhibiting or delaying the...
Invention Novel therapy for prostate carcinoma. Disclosed herein are methods of inhibiting or delaying the ...
2011 Invention Novel treatment of prostate carcinoma. Disclosed herein are naphthoquinone analogs, such as plumb...
Invention Combination therapy for the treatment of prostate carcinoma. Disclosed herein are naphthoquinone ...